Loading quotes...

Forecast

Buy	1
Hold	0
Sell	0

News Go to news feed

Haleon publishes latest figures on share capital and voting rights

Haleon has announced that as of July 31, 2025, the company has a total of 8,987,651,560 issued ordinary shares, of which 3,880,205 are held as treasury shares. The total number of shares with voting rights therefore amounts to 8,983,771,355. This information serves as the basis for calculations in accordance with the transparency requirements of the Financial Conduct Authority. » More on de.investing.com
Haleon appoints new members to committees

Haleon has appointed Bláthnaid Bergin to the audit and risk committee and Matt Shattock to the environmental and social sustainability committee. The appointments took immediate effect and were made in accordance with UK listing rules. The announcement was published by company secretary Amanda Mellor. » More on de.investing.com
Haleon stock delivers 12.16 percent return over three years

An investment of £1,000 in Haleon three years ago would be worth £1,121.64 today, representing an increase of 12.16 percent. The calculation does not account for stock splits or dividends. Haleon was first listed on the stock exchange in July 2022 and currently has a market capitalization of £31.87 billion. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Haleon PLC has already paid €0.0842 in dividends. The last payout was in September.

Financials

In the last quarter, Haleon PLC had revenue of €3.19B and net profit of €469.43M

(EUR)	June 2025	YoY
Revenue	3.19B	-
Gross profit	2.06B	-
Net profit	469.43M	-
EBITDA	811.32M	-

Fundamentals

Metric	Value
Market capitalization	€40.23B
Number of shares	8.8B
52-week high/low	€5.16 - €3.72
Dividend yield	1.88%
Dividends TTM	€0.0842
Beta	0.24
P/E ratio	20.96
PEG ratio	3.56
P/B ratio	2.07
P/S ratio	3.00

Company profile

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.

Name	Haleon PLC
CEO	Brian James McNamara
Headquarters	Weybridge, su United Kingdom
Website	haleon.com
Sector	Consumer Staples
Industry	Personal Care Products
IPO	07/18/2022
Employees	24,561